The federal government's bold 2030 goal to end the HIV epidemic in the United States is at a critical juncture. While scientific breakthroughs have made this ambitious vision achievable, recent legal challenges and budget cuts threaten to derail decades of progress. 

In a new featured article for Employee Benefit Plan Review, Stephen Massey, Co-Founder of U.S. Business Action to End HIV, makes the business case for why HIV prevention should be part of your company’s workforce health strategy. With modern prevention and treatment tools enabling people with HIV to live full, healthy lives without transmitting the virus, employers have an unprecedented opportunity to help end the epidemic.

Massey provides HR leaders with a practical five-point action plan, from leveraging pharmacy claims data and identifying coverage gaps to normalizing HIV care through an inclusive workplace culture. As the 2030 deadline approaches, the choices benefits leaders make today — what their plans cover, how they communicate about health, and which communities they prioritize — will directly influence whether America achieves this historic public health goal.

Read the full article in Employee Benefit Plan Review and discover to strengthen your workforce, demonstrate true business leadership, and join a coalition of nearly 100 employers already taking action to end HIV.

About U.S. Business Action to End HIV

U.S. Business Action to End HIV was founded in 2022 by the Health Action Alliance, with support from ViiV Healthcare, to mobilize the private sector to help end HIV in the U.S. We offer free tools, resources, and events to help employers educate workers, fight stigma, improve access to HIV prevention and treatment services, and build connections to the communities that need it most.‍

‍Join the Coalition today.